The John Hancock Multifactor Mid Cap ETF (JHMM) seeks to track a multifactor index that measures mid-capitalization U.S. companies selected and weighted based on multiple quality, value, and momentum characteristics. This mid-cap equity ETF targets companies with market capitalizations typically between $2-10 billion.

How It Works

JHMM employs a rules-based, multifactor approach that screens mid-cap stocks for quality metrics (high return on equity, low debt), value characteristics (low price-to-earnings, price-to-book ratios), and momentum indicators (positive earnings revisions, price trends). Selected companies receive optimized weightings based on factor scores rather than market capitalization. The fund rebalances semi-annually to maintain factor exposures and typically holds 200-400 mid-cap positions with sector diversification constraints.

Key Features

  • Combines quality, value, and momentum factors in single mid-cap ETF, eliminating need for multiple factor exposures
  • Zero expense ratio makes it cost-competitive against traditional mid-cap index funds charging 0.05-0.20% annually
  • Targets mid-cap sweet spot often overlooked by large-cap focused portfolios while avoiding small-cap liquidity issues

Risks

  • This ETF can lose value if multifactor strategies underperform, particularly when growth stocks dominate markets regardless of valuation metrics
  • Mid-cap stocks typically experience 20-30% higher volatility than large-caps, amplifying losses during market downturns and economic uncertainty
  • Factor tilts may cause significant performance divergence from broad mid-cap indexes, potentially lagging for extended periods during style rotations

Who Should Own This

Best suited as a satellite holding (10-25% of equity allocation) for investors with 3-7 year time horizons seeking enhanced mid-cap exposure through factor investing. Medium-to-high risk tolerance required due to mid-cap volatility and factor concentration. Appeals to tactical investors wanting systematic value, quality, and momentum exposure.